NH - EVOK and SE among premarket losers March, 04 2019 09:08 AM NantHealth Inc. Evoke Pharma (NASDAQ:EVOK) -52% on receiving preliminary FDA communication on Gimoti NDA. More news on: Evoke Pharma, Inc., The Children's Place Retail Stores, Inc., Bio-Path Holdings, Inc., Stocks on the move, Read more ...